Tumor-specific expression of cytochrome P450 CYP1B1

Cancer Research

Volumn 57, Issue 14, 1997, Pages 3026-3031

  Murray, Graeme I ^a   Taylor, Martin C ^a   McFadyen, Morag C E ^a   McKay, Judith A ^a   Greenlee, William F ^b   Burke, M Danny ^c   Melvin, William T ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOCHROME P450 ISOENZYME; ENZYME ANTIBODY;

ANTIBODY SPECIFICITY; ARTICLE; CANCER; CANCER DIAGNOSIS; CONTROLLED STUDY; DRUG DEVELOPMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; NEOPLASMS; RNA, MESSENGER;

EID: 0030812372     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Wrighton, S. A., and Stevens, J. C. The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol., 22: 1-21, 1992
2. Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, J. M. Estabrook, R. W., Gunsalus, I. C., and Nebert, D. W. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6: 1-42, 1996.
3. Shimada, T., and Guengerich, F. P. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol., 4: 391-407, 1991.
4. Nedelcheva, V., and Gut, I. P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer. Xenobiotica, 24: 1151-1175, 1994.
5. Park, B. K., Pirmohamed, M., and Kitteringham, N. R. The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicity. Pharmacol. & Ther., 68: 385-424, 1995.
6. Capdevila, J. H., Falck, J. R., and Estabrook, R. W. Cytochrome P450 and the arachidonate cascade. FASEB J., 6: 731-736, 1992.
7. Miller, W. L. Molecular biology of steroid hormone synthesis. Endocr. Rev., 9: 295-318, 1988.
8. Oliw, E. H. Oxygenation of polyunsaturated fatty acids by cytochrome P450 monooxygenases. Prog. Lipid Res., 33: 329-354, 1994.
9. Murray, G. I., and Burke, M. D. Immunohistochemistry of drug metabolizing enzymes. Biochem. Pharmacol., 50: 895-903, 1995.
10. Kaminsky, L. S., and Fasco, M. J. Small intestinal cytochromes P450. Crit. Rev. Toxicol., 21: 407-422, 1992.
11. Schuetz, E. G., Schuetz, J. D., Grogan, W. M., Naray-Fejes-Toth, A., Fejes-Toth, G., Raucy, J., Guzelian, P., Gionel, K., and Walington, C. O. Expression of cytochrome P450 3A in amphibian, rat and human kidney. Arch. Biochem. Biophys., 294: 206-214, 1992.
12. Jaiswal, A. K., Gonzalez, F. J., and Nebert, D. W. Human dioxin-inducible cytochrome P1 450: complementary DNA and amino acid sequence. Science (Washington DC), 228: 80-83, 1985.
13. Jaiswal, A. K., Nebert, D. W., and Gonzalez, F. J. Human P3-450: cDNA and complete amino acid sequence. Nucleic Acids Res., 14: 6773-6774, 1986.
14. Sesardic, D., Pasanen, M., Pelkonen, O., and Boobis, A. R. Differential expression and regulation of the cytochrome P450IA gene subfamily in human tissues. Carcinogenesis (Lond.), 11: 1183-1188, 1990.
15. Schweikl, H., Taylor, J. W., Kitareewan, S., Linko, P., Nagorney, D., and Goldestein, J. A. Expression of CYP1A1 and CYP1A2 in human liver. Pharmacogenetics, 3: 239-249, 1993.
16. Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y. Y. P., Jabs, E. W., Li, X., Yin, H., Cody, C. W., and Greenlee, W. F. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem., 269: 13092-13099, 1994.
17. Bhattacharyya, K. K., Brake, P. B., Eltom, S. E., Otto, S. A., and Jefcoate, C. R. Identification of a rat adrenal cytochrome P450 active in polycyclic hydrocarbon metabolism as rat CYP1B1. J. Biol. Chem., 270: 11595-11602, 1995.
18. Walker, N. J., Gastel, J. A., Costa, L. T., Clark, G. C., Lucier, G. W., and Sutter, T. R. Rat CYP1B1: an adrenal cytochrome P450 that exhibits sex-dependent expression in livers and kidneys of TCDD-treated animals. Carcinogenesis (Lond.), 16: 1319-1327, 1995.
19. Savas, Ü., Bhattacharyya, K. K., Christou, M., Alexander, D. L., and Jefcoate, C. R. Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. J. Biol. Chem., 269: 14905-14911, 1994.
20. Gonzalez, F. J., and Gelboin, H. V. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab. Rev., 26: 165-183, 1994.
21. Kawajiri, K., and Fujii-Kuriyama, Y. P450 and human cancer. Jpn. J. Cancer Res., 82: 1325-1335, 1991.
22. Guengerich, F. P. Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy Cancer Res., 48: 2946-2954, 1988.
23. Guengerich, F. P. Metabolic activation of carcinogens. Pharmacol. & Ther., 54: 17-62, 1992.
24. Kivisto, K. T., Kroemer, H. K., and Eichelbaum, M. The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions. Br. J. Clin. Pharmacol., 40: 523-530, 1995.
25. Albin., N., Massaad, L., Toussaint, C., Mathieu, M. C., Morizet, J., Parise, O., Gouyette, A., and Chabot, G. G. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues. Cancer Res., 53: 3541-3546, 1993.
26. Toussaint, C., Albin, N., Massaad, L., Grunenwald, D., Parise, O., Morizet, J., Gouyette, A., and Chabot, G. C. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peri-tumoral tissues. Cancer Res., 53: 4606-4612, 1993.
27. Czerwinski, M., McLemore, T. L., Gelboin, H. V., and Gonzalez, F. J. Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors. Cancer Res., 54: 1085-1091, 1994.
28. Peters, W. H. M., Boon, C. E. W., Roelofs, H. M. J., Wobbes, T., Nagengast, F. M., and Kremers, P. G. Expression of drug-metabolizing enzymes and P-170 glycoprotein in colorectal carcinoma and normal mucosa. Gastroenterology, 103: 448-455, 1992.
29. de Waziers, I., Cugnenc, P. H., Berger, A., Leroux, J-P., and Beaune, P. H. Drug-metabolizing enzyme expression in human normal, peritumoral and tumoral colorectal tissue samples. Carcinogenesis (Lond.), 12: 905-909, 1991.
30. Massaad, L., de Waziers, I., Ribrag, V., Janot, F., Beaune, P. H., Morizet, J., Gouyette, A., and Chabot, G. G. Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems. Cancer Res., 52: 6567-6575, 1992.
31. Mekhail-Ishak, K.,. Hudson, N., Ming-Sound, T., and Batist, G. Implications for therapy of drug-metabolizing enzymes in human colon cancer. Cancer Res., 49: 4866-4869, 1989.
32. Janot, F., Massaad, L., Ribrag, V., de Waziers, I., Beaune, P. H., Luboinski, B., Parise, O., Gouyette, A., and Chabot, G. G. Principal xenobiotic-metabolising enzyme systems in human head and neck squamous cell carcinoma. Carcinogenesis (Lond.), 14: 1279-1283, 1993.
33. Murray, G. I., Foster, C. O., Barnes, T. S., Weaver, R. J., McKay, J. A., Ewen, S. W. B., Melvin, W. T., and Burke, M. D. Expression of cytochrome P450IA in breast cancer. Br. J. Cancer, 63: 1021-1023, 1991.
34. Murray, G. I., McKay, J. A., Weaver, R. J., Ewen, S. W. B., Melvin, W. T., and Burke, M. D. Cytochrome P450 expression is a common molecular event in soft tissue sarcomas. J. Pathol., 171: 49-52, 1993.
35. Nakajima, T., Wang, R. S., Nimura, Y., Pin, Y. M., He, M., Vainio, H., Murayama, N., Aoyama, T., and Iida, F. Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous-cell carcinomas. Carcinogenesis (Lond.), 17: 1477-1481, 1996.
36. Murray, G. I., Shaw, D., Weaver, R. J., McKay, J. A. Ewen, S. W. B., Melvin, W. T., and Burke, M. D. Cylochrome P450 expression in oesophageal cancer. Gut, 35: 599-603, 1994.
37. McKay, J. A. Melvin, W. T., Ah-See, A. K., Ewen, S. W. B., Greenlee, W. F., Marcus, C. B., Burke, M. D., and Murray, G. I. Expression of cytochrome P450 CYP1B1 in breast cancer. FEBS Lett.,374: 270-272, 1995.
38. Weaver, R. J., Dickins, M., and Burke, M. D. Cytochrome P450 2C9 is responsible for hydroxylation of the naphthoquinone antimalarial drug 58C80 in human liver. Biochem. Pharmacol., 46: 1183-1197, 1993.
39. Kress, S., and Greenlee, W. F. Cell specific regulation of human CYP1A1 and CYP1B1 genes. Cancer Res., 57: 1264-1269, 1997.
40. McKay, J. A., Weaver, R. J., Murray, G. I., Ewen, S. W. B., Melvin, W. T., and Burke, M. D. Expression of microsomal epoxide hydrolase in normal and neoplastic human kidney. J. Histochem. Cytochem., 43: 615-620, 1995.
41. Weaver, R. J., Thompson, S., Smith, G., Dickins, M., Elcombe, C. R., Mayer, R. T., and Burke, M. D. A comparative study of constitutive and inducible alkoxyresorufin o-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, rat and hamster liver microsomes. Biochem. Pharmacol., 47: 763-773, 1994.
42. Buchmann, A., Kuhlman, W., Schwarz, M., Kunz, W., Wolf, C. R., Moll, E., Freidberg, T., and Oesch, F. Regulation and expression of four cytochrome P-450 isoenzymes, NADPH-cytochrome P-450 reductase, the glutathione transferases B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver. Carcinogenesis (Lond.), 6: 513-521, 1985.
43. Roomi, M. W., Ho, R. K., Sarma, D. S. R., and Farber, E. A common biochemical pattern in preneoplastic hepatocyte nodules generated in four different models the rat. Cancer Res., 45: 564-571, 1985.
44. Buchmann, A., Schwarz, M., Schmitt, R., Wolf, C. R., Oesch, F., and Kunz, W. Development of cytochrome P-450-altered preneoplastic and neoplastic lesions during nitrosamine-induced hepatocarcinogenesis in the rat. Cancer Res., 47: 2911-2918, 1987.
45. Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., and Sutter, T. R. Activation of a chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res., 56: 2979-2984, 1996.
46. Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., and Sutter, T. R. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. USA, 93: 9776-9781, 1996.
47. Liehr, J. G., Ricci, M. J., Jefcoate, C. R., Hannigan, E. V., Hokanson, J. A., and Zhu, B. T. 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc. Natl. Acad. Sci. USA, 92: 9220-9224, 1995.
48. Spink, D. C., Hayes, C. L., Young, N. R., Christou, M., Sutter, T. R., Jefcoate, C. R., and Gierthy, J. F. The effects of 2,3,7,8-tetrachlorodibenzo-ρ-dioxin on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17β-estradiol 4-hydroxylase. J. Steroid Biochem. Mol. Biol., 51: 251-258, 1994.
49. Liehr, J. G., and Ricci, M. J. 4-Hydroxylation of estrogens as markers of human mammary tumors. Proc. Natl. Acad. Sci. USA, 93: 3294-3296, 1996.